HERSTELLUNG VON FETUIN A

European patent · EP3865143 · In force

Register entry

Publication number
EP3865143
Application number
EP20020074
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 17, 2020
Published
Aug 18, 2021
Granted
Dec 24, 2025
Protection ends at the latest
Feb 16, 2040
Next annual fee due
Feb 28, 2027
IPC classes
A61K 38/00 (2006.01)
C07K 14/47 (2006.01)
C12P 21/00 (2006.01)
G01N 30/02 (2006.01)
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 20, 2026

    Agent’s address changed

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich → Dr. Lusuardi AG, Stockerstrasse 8, 8002 Zürich

    Published in Swissreg on 20.10.2026

  2. Mar 26, 2026

    Next annual fee due on

    Next annual fee due on
    28.02.2026 → 28.02.2027

    Published in Swissreg on 26.03.2026

  3. Feb 20, 2026

    Agent entered

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 20.02.2026

  4. Dec 24, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 24.12.2025

Parties

Holder

PreviPharma GmbH

CUBEX 41 Universitätsmedizin Mannheim Haus 41 Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, DE

Agent

Dr. Lusuardi AG

Stockerstrasse 8, 8002 Zürich

Inventor

Kießig, Stephan T.

69168 Wiesloch, DE

Berger, Tina

64625 Bensheim, DE

Mandago, Maurice

69250 Schönau, DE

Gruber, Ricarda

69256 Mauer, DE

Gerding, Hanne

68229 Mannheim, DE

Müller, Dirk

68165 Mannheim, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.